Literature DB >> 20298357

Attributable fractions for partitioning risk and evaluating disease prevention: a practical guide.

Geir E Eide1.   

Abstract

INTRODUCTION: The attributable fraction (AF) is used for quantifying the fraction of diseased ascribable to one or more exposures. The methodology and software for its estimation has undergone a considerable development during the last decades.
OBJECTIVES: To introduce methods for: (i) apportioning excess risk to multiple exposures, groups of exposures and subpopulations; (ii) graphical description; and (iii) survival data.
RESULTS: Adjusted, sequential and average AFs are reasonable measures obtainable with standard software. The latter two both sum up to the combined AF for a set of exposures. The average AFs are independent of the exposures' ordering. For an ordered, preventive strategy, scaled sample space cubes illustrate the effects on the risk of disease from stepwise exposure removal. Pie charts illustrate the portions of the total risk ascribed to different exposures or risk-profiles. Attributable hazard fraction, AF before time t, and AF within study incorporate time to disease and interventions.
CONCLUSIONS: The practice of crude calculations of AFs in epidemiology should be abandoned. Further development of methods for AFs with survival data and possibly linking it to causal modelling is of interest.

Entities:  

Mesh:

Year:  2008        PMID: 20298357     DOI: 10.1111/j.1752-699X.2008.00091.x

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  9 in total

1.  Proportion of selected congenital heart defects attributable to recognized risk factors.

Authors:  Regina M Simeone; Sarah C Tinker; Suzanne M Gilboa; A J Agopian; Matthew E Oster; Owen J Devine; Margaret A Honein
Journal:  Ann Epidemiol       Date:  2016-10-26       Impact factor: 3.797

2.  Proportion of Orofacial Clefts Attributable to Recognized Risk Factors.

Authors:  Janhavi R Raut; Regina M Simeone; Sarah C Tinker; Mark A Canfield; R Sue Day; A J Agopian
Journal:  Cleft Palate Craniofac J       Date:  2018-05-04

3.  Proportion of neural tube defects attributable to known risk factors.

Authors:  A J Agopian; Sarah C Tinker; Philip J Lupo; Mark A Canfield; Laura E Mitchell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-01

4.  Tuberculosis and indoor biomass and kerosene use in Nepal: a case-control study.

Authors:  Amod K Pokhrel; Michael N Bates; Sharat C Verma; Hari S Joshi; Chandrashekhar T Sreeramareddy; Kirk R Smith
Journal:  Environ Health Perspect       Date:  2010-04       Impact factor: 9.031

5.  Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research.

Authors:  Ali Mirzazadeh; Mohsen Malekinejad; James G Kahn
Journal:  J Clin Epidemiol       Date:  2014-12-18       Impact factor: 7.407

6.  Avoidable Burden of Risk Factors for Serious Road Traffic Crashes in Iran: A Modeling Study.

Authors:  Fatemeh Khosravi Shadmani; Kamyar Mansori; Manoochehr Karami; Farid Zayeri; Reza Khosravi Shadman; Shiva Mansouri Hanis; Hamid Soori
Journal:  J Prev Med Public Health       Date:  2017-02-06

7.  Acute lower respiratory infection in childhood and household fuel use in Bhaktapur, Nepal.

Authors:  Michael N Bates; Ram K Chandyo; Palle Valentiner-Branth; Amod K Pokhrel; Maria Mathisen; Sudha Basnet; Prakash S Shrestha; Tor A Strand; Kirk R Smith
Journal:  Environ Health Perspect       Date:  2013-03-19       Impact factor: 9.031

8.  Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder.

Authors:  B S Solberg; A Halmøy; A Engeland; J Igland; J Haavik; K Klungsøyr
Journal:  Acta Psychiatr Scand       Date:  2017-12-21       Impact factor: 6.392

9.  The proportion of perioperative mortalities attributed to cemented implantation in hip fracture patients treated by hemiarthroplasty.

Authors:  Are Hugo Pripp; Ove Talsnes; Olav Reikerås; Lars B Engesæter; Ola E Dahl
Journal:  Hip Int       Date:  2014-02-11       Impact factor: 2.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.